|
|
|
Volumn 38, Issue 4, 2013, Pages
|
|
Pharmaceutical approval update
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALOGLIPTIN;
BISPHOSPHONIC ACID DERIVATIVE;
BORTEZOMIB;
CYTOCHROME P450 2C8;
KAZANO;
LENALIDOMIDE;
LINAGLIPTIN;
METFORMIN;
OSENI;
OXYBUTYNIN;
PIOGLITAZONE;
PLACEBO;
POMALIDOMIDE;
POMALYST;
SAXAGLIPTIN;
SITAGLIPTIN;
UNCLASSIFIED DRUG;
ACUTE PANCREATITIS;
ANGIONEUROTIC EDEMA;
BLADDER CANCER;
CLINICAL TRIAL (TOPIC);
CONFUSION;
CONGESTIVE HEART FAILURE;
CYANOCOBALAMIN DEFICIENCY;
DEEP VEIN THROMBOSIS;
DIABETIC MACULAR EDEMA;
DIZZINESS;
DRUG APPROVAL;
DRUG DOSE ESCALATION;
DRUG WITHDRAWAL;
EDEMA;
EMBRYOTOXICITY;
ESOPHAGITIS;
FRACTURE;
HUMAN;
HYPERSENSITIVITY;
HYPOGLYCEMIA;
LACTIC ACIDOSIS;
LIVER FAILURE;
MULTIPLE CYCLE TREATMENT;
MULTIPLE MYELOMA;
MYASTHENIA GRAVIS;
NEUROPATHY;
NEUTROPENIA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
OVERACTIVE BLADDER;
OVULATION;
RACEMIC MIXTURE;
RECOMMENDED DRUG DOSE;
SECOND CANCER;
SIDE EFFECT;
SKIN ALLERGY;
THROMBOCYTOPENIA;
URINE RETENTION;
VENOUS THROMBOEMBOLISM;
|
|
EID: 84876234290
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|
